Search
News
Important Only
Stocks
US health insurers gain on Centene CEO's remarks on Medicaid
** Stocks of U.S. health insurers rose in morning trading following comments by the Centene CNC.N CEO that Medicaid results for July and August support an improved trajectory for the back half of the year** Centene also said in a filing that its financial results through August are consistent with i...Reuters
Thu, Sep 11
Stocks
Opinion: The Stock Market Is on Shakier Ground Than Wall Street Seems to Think
Key PointsEconomic uncertainty and steep valuations present key risks for stocks.However, analysts remain overwhelmingly bullish.10 stocks we like better than S&P 500 Index › Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. C...The Motley Fool
Thu, Sep 11
Stocks
Centene shares rise after reaffirmed profit forecast, steady Medicare ratings
By Sriparna Roy Sept 11 (Reuters) - Centene CNC.N shares gained more than 11% in early trading on Thursday after the health insurer reaffirmed its annual profit forecast and said quality ratings for its Medicare plans were in line with expectations.Preliminary data for Star or quality ratings fo...Reuters
Thu, Sep 11
Other
French lawmaker asks prosecutor to probe TikTok for 'endangering the lives' of users
PARIS, Sept 11 (Reuters) - The chairman of a French parliamentary committee investigating TikTok's psychological effects on minors said on Thursday that he had asked for a criminal probe into TikTok's possible responsibility for "endangering the lives" of its young users. The committ...Reuters
Thu, Sep 11
Commodities
SOFTS-Arabica coffee slips from four-month highs while cocoa gains
LONDON, Sept 11 (Reuters) - Arabica coffee futures on ICE slipped on Thursday, with the market consolidating after hitting four-month highs this week, while cocoa headed higher. COFFEE* Arabica coffee KCc2 edged down 0.1% to $3.8670 per lb at 1341 GMT, having hit its highest since early May at $...Reuters
Thu, Sep 11
Stocks
1 Small-Cap Biotech Stock Poised for a Breakout
Key PointsaTyr Pharma's leading candidate is targeting a relatively large market with unmet needs. The biotech company is expected to release data from a phase 3 clinical trial soon.Though things look somewhat promising for the company, aTyr Pharma is a risky stock. 10 stocks we like better than aTy...The Motley Fool
Thu, Sep 11
Stocks
US STOCKS-Wall St advances as Fed rate cut bets remain intact after inflation data
August CPI at 0.4% MoM versus 0.3% estimatedMicron jumps after Citigroup hikes PTIndexes up: Dow 0.39%, S&P 500 0.29%, Nasdaq 0.26%By Purvi Agarwal and Shashwat Chauhan Sept 11 (Reuters) - Wall Street's main indexes rose on Thursday after the latest inflation data did little to alter mark...Reuters
Thu, Sep 11
Stocks
Amneal Pharma up after US FDA approves sodium oxybate solution
** Shares of drugmaker Amneal Pharmaceuticals AMRX.O rise 2% to $10.02** Company says the U.S. FDA has approved Amneal's sodium oxybate oral solution for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy** Amneal's solution is a g...Reuters
Thu, Sep 11
Forex
FOREX-US dollar eases after slightly hotter inflation, jobless claims uptick
US headline CPI rises 0.4%, year-on-year up 2.9%Initial jobless claims rise more than expected.Fed funds futures price in 91% odds of 25-bp rate cut next weekBy Gertrude Chavez-Dreyfuss NEW YORK, Sept 11 (Reuters) - The U.S. dollar slipped on Thursday after modestly hotter August inflation data a...Reuters
Thu, Sep 11
Other
RPT-Novo Nordisk tells staff to return to office full-time amid CEO's revival effort
News comes after layoffs announced on WednesdayOther companies, US administration have scrapped home workingNovo employees can still make individual arrangements COPENHAGEN, Sept 11 (Reuters) - Wegovy-maker Novo Nordisk NOVOb.CO said on Thursday it had told all its staff to return to the office a...Reuters
Thu, Sep 11
Other
GRI Bio Reports 6-Week Interim Lung Function Data In Ongoing Phase 2A Study In Idiopathic Pulmonary Fibrosis
Sept 11 (Reuters) - GRI Bio Inc GRI.O:GRI BIO REPORTS 6-WEEK INTERIM LUNG FUNCTION DATA IN ONGOING PHASE 2A STUDY IN IDIOPATHIC PULMONARY FIBROSIS (“IPF”)GRI BIO INC - GRI-0621 SHOWS NO WORSENING OF FVC AT 6 WEEKSGRI BIO INC - PHASE 2A STUDY FULLY ENROLLED; TOPLINE DATA EXPECTED Q3 2025GRI BIO INC -...Reuters
Thu, Sep 11
Economic Indicator
Litigation funding business sues co-founder, law firm for $100 million over trade secrets
By Mike Scarcella Sept 9 (Reuters) - U.S. litigation funding business Archetype Capital Partners has sued one of its co-founders and a law firm, accusing them of stealing client information and other internal business secrets.The lawsuit, filed on Monday in federal court in Nevada, said Archetype...Reuters
Thu, Sep 11
Stocks
Absci Collaborates with Oracle and AMD to Speed up AI-Led Drug Discovery, Shares Jump
Absci on Thursday announced a collaboration with Oracle Cloud Infrastructure and AMD to accelerate its AI-driven drug discovery efforts.Absci shares jumped 9.5 in morning trading.As part of the partnership, the Vancouver, Washington-based biotech will use Oracle’s AI infrastructure and AMD’s hardwar...Tiger News
Thu, Sep 11
Stocks
Bet on the Vegas Strip With This Income Stock
Key PointsVici Properties is the largest owner of casino real estate in the U.S., including a substantial portfolio on the Las Vegas Strip.Buoyed by strong adjusted funds from operations (AFFO) guidance and the possibility of more accommodative monetary policy, the REIT is trouncing broader real est...The Motley Fool
Thu, Sep 11
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback
Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora
POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now
Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?
Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?
Tradingkey
